BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 18614276)

  • 1. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organization of the human aromatase p450 (CYP19) gene.
    Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
    Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
    Ghosh S; Lu Y; Katz A; Hu Y; Li R
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.
    Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase gene expression in adipose tissue: relationship to breast cancer.
    Simpson ER; Mahendroo MS; Nichols JE; Bulun SE
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():75-83. PubMed ID: 7874190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
    Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
    Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of inhibition of sodium butyrate on activation of tumor associated aromatase promoters].
    Zhou JF; Liu WL; Chen G; Lu YP; Ma D
    Ai Zheng; 2002 Dec; 21(12):1283-7. PubMed ID: 12520731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
    Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
    Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Bulun SE
    N Engl J Med; 2003 May; 348(19):1855-65. PubMed ID: 12736278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of aromatase in breast cancer tissues.
    Harada N
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
    Kijima I; Ye J; Glackin C; Chen S
    Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disorders associated with inappropriately high aromatase expression.
    Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aromatase--key enzyme of estrogen biosynthesis].
    Milczarek R; Klimek J
    Postepy Biochem; 2005; 51(4):430-9. PubMed ID: 16676578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.